Dapagliflozin 10 mg
D1693C00001
Phase 3 small_molecule completed
Quick answer
Dapagliflozin 10 mg for Diabetes Mellitus, Non-Insulin-Dependent is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Diabetes Mellitus, Non-Insulin-Dependent
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed